From Elle Fanning and Gus Wenner to Chris Hemsworth and Elsa Pataky to Lebron and Savannah James and more Stephanie Sengwe is a pop culture enthusiast with over 10 years of experience working as a ...

Technology’s at a crossroads, it seems, as we close out 2025. While OpenAI’s brash CEO Sam Altman mounts stages across the country to announce the imminent arrival of AI ”superintelligence,” two new ...

If you have ever sworn off social media for a week or two because you sensed it was feeding your anxiety or dampening your mood, you may be on to something. A new study out last week in JAMA Network ...

A century ago, two oddly domestic puzzles helped set the rules for what modern science treats as "real": a Guinness brewer charged with quality control and a British lady insisting she can taste ...

This study aimed to explore the correlations between organizational cynicism, burnout, and socio-demographic variables. The sample consisted of 553 Turkish Republic of Northern Cyprus (TRNC) secondary ...

Chief Research Scientist, CSIRO Environment; Executive Director, Global Carbon Project, CSIRO Pep Canadell receives funding from the Australian National Environmental Science Program - Climate Systems ...

Campaign manager at Waspi, Jane Cowley, tells Sky's Wilfred Frost that the payment would "make a very significant difference to millions of women". Wealthy foreigners ‘paid £80k for weekend safaris to ...

Objectives To inform about behavioural gender and age differences in compliance with hand hygiene recommendations during the COVID-19 pandemic in Switzerland. Design Observational study (24–25 June ...

For the first time, Akeso and Summit Therapeutics’ closely watched PD-1xVEGF bispecific antibody has shown that it can extend patients’ lives. A “statistically significant and clinically meaningful” ...

Rihanna may steal A$AP Rocky’s clothes, but he just stole her whole look. While Rocky did not go shirtless like his partner, his boxer-inspired waistband feels like ...

ProKidney’s cell therapy for kidney disease failed to demonstrate a clinically significant preservation of kidney function in one part of a phase 2 study, but the biotech has pointed to the trial’s ...